// App-Quantinova.ai

WP263 2016 ASA : Mutagenesis Studies Revealed Minimal Impact of Human A120T Variant of Protease-activated Receptor 4 on Receptor function or Pharmacological Response to a Potent and Selective Antagonist

Researchers

Presenter

  • Jeffrey Colin

Principal Investigators

  • Sophie Desmeules

  • Roger Remillard

  • Jacques Banville

  • Anne Marinier

  • Scott Priestley

  • Michel Bouvier

  • Jing Yang

  • Chi Sum

  • Tao Wang

  • John Feder

  • Gabe Mintier

  • Ke Xu

  • Zhaoqing Wang

  • Fraz Ismat

  • Xuewen Ma

Medical Centers

  • University of Montreal, Montreal, QC, Canada

Locations

  • Canada

Companies

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved